DK125407B - Fremgangsmåde til fremstilling af et stabilt, i de væsentlige ikke-ionisk, colloidt ferrihydroxidkompleks af hydrogeneret dextran. - Google Patents

Fremgangsmåde til fremstilling af et stabilt, i de væsentlige ikke-ionisk, colloidt ferrihydroxidkompleks af hydrogeneret dextran.

Info

Publication number
DK125407B
DK125407B DK335564AA DK335564A DK125407B DK 125407 B DK125407 B DK 125407B DK 335564A A DK335564A A DK 335564AA DK 335564 A DK335564 A DK 335564A DK 125407 B DK125407 B DK 125407B
Authority
DK
Denmark
Prior art keywords
ionic
stable
preparation
substantially non
ferric hydroxide
Prior art date
Application number
DK335564AA
Other languages
English (en)
Inventor
N Floramo
Original Assignee
Chem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Inc filed Critical Chem Inc
Publication of DK125407B publication Critical patent/DK125407B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
DK335564AA 1963-09-13 1964-07-03 Fremgangsmåde til fremstilling af et stabilt, i de væsentlige ikke-ionisk, colloidt ferrihydroxidkompleks af hydrogeneret dextran. DK125407B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US308642A US3234209A (en) 1963-09-13 1963-09-13 Process for making iron hydrogenated dextran

Publications (1)

Publication Number Publication Date
DK125407B true DK125407B (da) 1973-02-19

Family

ID=23194801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK335564AA DK125407B (da) 1963-09-13 1964-07-03 Fremgangsmåde til fremstilling af et stabilt, i de væsentlige ikke-ionisk, colloidt ferrihydroxidkompleks af hydrogeneret dextran.

Country Status (8)

Country Link
US (1) US3234209A (da)
BR (1) BR6460308D0 (da)
DE (1) DE1443665A1 (da)
DK (1) DK125407B (da)
FI (1) FI44451C (da)
GB (1) GB1040467A (da)
NO (1) NO116641B (da)
SE (1) SE324207B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549614A (en) * 1967-07-13 1970-12-22 Jan Zbigniew Mioduszewski Method of manufacture of mixed complex compounds of ferric iron with hydrogenated dextran and citric acid or sodium citrate
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
US4507472A (en) * 1983-06-14 1985-03-26 Usher Thomas C Manufacture of diethylaminoethyl dextrans
US4770183A (en) * 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
US5219554A (en) * 1986-07-03 1993-06-15 Advanced Magnetics, Inc. Hydrated biodegradable superparamagnetic metal oxides
US4951675A (en) * 1986-07-03 1990-08-28 Advanced Magnetics, Incorporated Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
WO2000061191A2 (en) * 1999-04-09 2000-10-19 Advanced Magnetics, Inc. Heat stable coated colloidal iron oxides
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
US6703499B1 (en) 1999-04-29 2004-03-09 Polydex Pharmaceuticals Ltd. Process of making carboxylated dextran

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3022221A (en) * 1959-04-16 1962-02-20 Chemicals Inc Iron hydrogenated dextran

Also Published As

Publication number Publication date
US3234209A (en) 1966-02-08
NO116641B (da) 1969-04-28
FI44451C (fi) 1971-11-10
GB1040467A (en) 1966-08-24
FI44451B (da) 1971-08-02
DE1443665A1 (de) 1968-12-05
SE324207B (da) 1970-05-25
BR6460308D0 (pt) 1973-09-11

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner.
DK106552C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner.
DK125407B (da) Fremgangsmåde til fremstilling af et stabilt, i de væsentlige ikke-ionisk, colloidt ferrihydroxidkompleks af hydrogeneret dextran.
DK105708C (da) Fremgangsmåde til fremstilling af vanduopløselige monoazofarvestoffer.
DK111387B (da) Fjedermekanisme til drejestol.
DK106185C (da) Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner.
DK120752B (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.
DK122890B (da) Fremgangsmåde til fremstilling af ferrihydroxiddextrankomplekser.
DK106328C (da) Fremgangsmåde til fremstilling af 17α-alkoxy-16-methylen-3,20-diketopregnanderivater.
DK105485C (da) Fremgangsmåde til fremstilling af vanduopløselige monoazofarvestoffer.
DK121757B (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10,11-dihydroxy-5-(3-substituerede aminopropyliden)-5H-dibenzo-[a,d]-cycloheptenforbindelser.
DK114273B (da) Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler.
DK109260C (da) Fremgangsmåde til fremstilling af 3,5-diklor-2, 6-dimetyl-4-pyridinol.
DK119702B (da) Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK118818B (da) Fremgangsmåde til fremstilling af 3-keto-4,6-bisdehydro-9β,10α-steroider.
DK122398B (da) Fremgangsmåde til fremstilling af ferrihydroxid-kompleksforbindelser af hydrogeneret dextran.
DK119354B (da) Fremgangsmåde til fremstilling af 3-sulfamoyl-5-tert.-aminopropyliden-5H-dibenzo-[a,d]-cycloheptener.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK121297B (da) Fremgangsmåde til fremstilling af 19-hydroxyandrost-4-en-3,17-dion.
DK114902B (da) Fremgangsmåde til fremstilling af O,S-disubstituerede thiol-thiaminderivater.
DK105036C (da) Fremgangsmåde til fremstilling af 7-desacetylamino-11,12-dihydrocolchicein.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.